HCPCS Code M0249
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
| Short Description | Adm tocilizu covid-19 1st |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | June 24, 2021 |
| Code Added Date | June 24, 2021 |
| Pricing Indicator | 54 = Vaccinations |
| Type of Service | V = Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95 - 12/95), Pneumococcal only before 04/95 |